Navigating complexity with low-crossing profile dual-layer micromesh carotid stent: implications for contemporary carotid artery stenting outcomes (ROADSAVER study insights).

Ralf Langhoff, Arne Schwindt, Zsolt Vajda, Aleksander Gjoreski, Benjamin Faurie, Sasko Kedev, Stefan Müller-Hülsbeck
{"title":"Navigating complexity with low-crossing profile dual-layer micromesh carotid stent: implications for contemporary carotid artery stenting outcomes (ROADSAVER study insights).","authors":"Ralf Langhoff, Arne Schwindt, Zsolt Vajda, Aleksander Gjoreski, Benjamin Faurie, Sasko Kedev, Stefan Müller-Hülsbeck","doi":"10.23736/S0021-9509.24.13068-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The safety and efficacy of carotid artery stenting (CAS) can be affected by certain technical and anatomical factors. However, it is not known whether the use of a dual-layer micromesh stent (DLMS) with a low-crossing profile could reduce the risks associated with complex vascular anatomies during CAS.</p><p><strong>Methods: </strong>This study involved 1965 asymptomatic or symptomatic carotid artery stenosis patients who received the Roadsaver DLMS during CAS, as part of a prospective, multicenter observational ROADSAVER study, conducted from January 2018 to February 2021. The primary outcome was the 30-day rate of major adverse events (MAE; i.e. any death or stroke) after CAS. Procedural details and outcomes were compared between patients with complex anatomical features and those without.</p><p><strong>Results: </strong>One or more complex anatomical characteristics were identified in 1639 (83.4%) patents. Patients with complex anatomies were older and had a higher prevalence of arterial hypertension, cardiovascular disease, and prior stroke. Between patients with or without complex anatomical features, no significant differences were found either in procedural techniques, or in 30-day MAE (age-adjusted odds ratio (95% CI) for complexities vs. no complexities: 0.76 (0.35, 1.66); p=0.4905) and any stroke (age-adjusted odds ratio (95% CI) for complexities vs. no complexities: 0.89 (0.37, 2.17); p=0.8032) incidence. Furthermore, neither the presence of specific types of anatomic complexity nor their number (per patient) markedly influenced the 30-day MAE and any stroke incidence.</p><p><strong>Conclusions: </strong>In this real-world cohort of patients undergoing CAS with the Roadsaver DLMS, no significant difference in the occurrence of 30-day MAE and any stroke was observed between patients with or without high-risk anatomical features.</p>","PeriodicalId":101333,"journal":{"name":"The Journal of cardiovascular surgery","volume":"65 3","pages":"205-212"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of cardiovascular surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0021-9509.24.13068-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The safety and efficacy of carotid artery stenting (CAS) can be affected by certain technical and anatomical factors. However, it is not known whether the use of a dual-layer micromesh stent (DLMS) with a low-crossing profile could reduce the risks associated with complex vascular anatomies during CAS.

Methods: This study involved 1965 asymptomatic or symptomatic carotid artery stenosis patients who received the Roadsaver DLMS during CAS, as part of a prospective, multicenter observational ROADSAVER study, conducted from January 2018 to February 2021. The primary outcome was the 30-day rate of major adverse events (MAE; i.e. any death or stroke) after CAS. Procedural details and outcomes were compared between patients with complex anatomical features and those without.

Results: One or more complex anatomical characteristics were identified in 1639 (83.4%) patents. Patients with complex anatomies were older and had a higher prevalence of arterial hypertension, cardiovascular disease, and prior stroke. Between patients with or without complex anatomical features, no significant differences were found either in procedural techniques, or in 30-day MAE (age-adjusted odds ratio (95% CI) for complexities vs. no complexities: 0.76 (0.35, 1.66); p=0.4905) and any stroke (age-adjusted odds ratio (95% CI) for complexities vs. no complexities: 0.89 (0.37, 2.17); p=0.8032) incidence. Furthermore, neither the presence of specific types of anatomic complexity nor their number (per patient) markedly influenced the 30-day MAE and any stroke incidence.

Conclusions: In this real-world cohort of patients undergoing CAS with the Roadsaver DLMS, no significant difference in the occurrence of 30-day MAE and any stroke was observed between patients with or without high-risk anatomical features.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用低横截面双层微网状颈动脉支架驾驭复杂性:对当代颈动脉支架治疗效果的影响(ROADSAVER 研究启示)。
背景:颈动脉支架植入术(CAS)的安全性和有效性会受到某些技术和解剖因素的影响。然而,使用具有低交叉轮廓的双层微孔支架(DLMS)能否降低 CAS 过程中与复杂血管解剖相关的风险,目前尚不清楚:本研究涉及 1965 名无症状或有症状的颈动脉狭窄患者,他们在 CAS 期间接受了 Roadsaver DLMS,这是一项前瞻性、多中心观察性 ROADSAVER 研究的一部分,于 2018 年 1 月至 2021 年 2 月进行。主要结果是CAS术后30天的主要不良事件(MAE;即任何死亡或中风)发生率。对具有复杂解剖特征和不具有复杂解剖特征的患者的手术细节和结果进行了比较:在1639例(83.4%)专利中发现了一种或多种复杂解剖特征。具有复杂解剖特征的患者年龄较大,动脉高血压、心血管疾病和中风的发病率较高。有或无复杂解剖特征的患者在手术技术或 30 天 MAE 方面均无明显差异(经年龄调整后,有复杂解剖特征与无复杂解剖特征的几率比(95% CI)为 0.76(0.35,0.35):0.76(0.35,1.66);P=0.4905)和任何卒中(复杂与不复杂的年龄调整后几率比(95% CI):0.89(0.37,1.66);P=0.4905):0.89(0.37,2.17);P=0.8032)。此外,特定类型解剖复杂性的存在或其数量(每位患者)都不会明显影响 30 天 MAE 和任何卒中的发生率:结论:在这个使用Roadsaver DLMS进行CAS手术的真实世界患者队列中,未观察到具有或不具有高风险解剖特征的患者在30天MAE和任何卒中的发生率上存在显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
相关文献
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV
IF 5.4 3区 医学PharmaceuticsPub Date : 2024-04-27 DOI: 10.3390/pharmaceutics16050594
Bryan T. Mayer, Lily Zhang, Allan C. deCamp, Chenchen Yu, Alicia Sato, Heather Angier, Kelly E. Seaton, Nicole Yates, Julie E. Ledgerwood, Kenneth Mayer, Marina Caskey, Michel Nussenzweig, Kathryn Stephenson, Boris Julg, Dan H. Barouch, Magdalena E. Sobieszczyk, Srilatha Edupuganti, Colleen F. Kelley, M. Juliana McElrath, Huub C. Gelderblom, Michael Pensiero, Adrian McDermott, Lucio Gama, Richard A. Koup, Peter B. Gilbert, Myron S. Cohen, Lawrence Corey, Ollivier Hyrien, Georgia D. Tomaras, Yunda Huang
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Safety and efficacy of an innovative external support device for de novo arterio-venous fistula creation: a French bicentric experience. Personalized decision-making for vascular access creation in hemodialysis. Hemodynamic considerations in arteriovenous vascular access modalities for hemodialysis. Acute type A aortic syndromes and ski: management in an emergency care network. A Belgian physician-initiated trial investigating the LifeStream peripheral stent graft system for the treatment of complex TASC C and D iliac lesions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1